Sharecafe

Syntara (ASX:SNT) – Webinar Presentation

Gary Phillips - CEO - Syntara (ASX:SNT) is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. The company has ongoing trials in myelofibrosis, myelodysplastic syndrome, scar prevention, modifcation of existing scars, isolated REM sleep behaviours disorder and Parkinson's Disease.

 

Gary Phillips – CEO – Syntara (ASX:SNT) is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. The company has ongoing trials in myelofibrosis, myelodysplastic syndrome, scar prevention, modifcation of existing scars, isolated REM sleep behaviours disorder and Parkinson's Disease.

BW_Ad_tile_aq
Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X

All Categories